Outset Medical, Inc. cash flow statement
In fiscal 2025, Outset Medical, Inc.'s operations generated −$46.3m of cash; it spent $798,000 on capital projects, leaving free cash flow of −$47.1m.
Cash flow statement
| Fiscal year | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −46 | −70 | −99 | −130 | −146 | −131 | −116 | −46 | −38 |
| Depreciation and amortisation | 1 | 1 | 3 | 5 | 5 | 6 | 6 | 4 | 3 |
| Stock-based pay | 1 | 1 | 21 | 17 | 27 | 39 | 29 | 16 | 15 |
| Capital spending | 2 | 3 | 9 | 3 | 8 | 3 | 1 | 1 | 1 |
| Free cash flow | −48 | −74 | −108 | −133 | −154 | −135 | −117 | −47 | −39 |
| Free cash flow after stock pay | −49 | −74 | −130 | −151 | −181 | −173 | −147 | −63 | −54 |
| Shares issued | — | — | 255 | 149 | 0 | 0 | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −21 | −16 | −26 | −5 | −6 | −10 | −13 | −10 |
| Depreciation and amortisation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Stock-based pay | 6 | 5 | 3 | 3 | 5 | 4 | 3 | 3 |
| Capital spending | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −21 | −17 | −26 | −5 | −6 | −10 | −13 | −10 |
| Free cash flow after stock pay | −27 | −21 | −29 | −9 | −12 | −14 | −16 | −12 |
Compare with peers
- Anika Therapeutics, Inc. cash flow
- Owlet, Inc. cash flow
- Sanara Medtech Inc. cash flow
- Xtant Medical Holdings, Inc. cash flow
- Beta Bionics, Inc. cash flow
Head to head: ANIK vs OMOM vs OWLTOM vs SMTIBBNX vs OM
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies